Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A pH-responsive silica–metal–organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries
Yuyuan Wang, Pawan K. Shahi, Ruosen Xie, et al.
Journal of Controlled Release (2020) Vol. 324, pp. 194-203
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
Song Zhang, Jiangtao Shen, Dali Li, et al.
Theranostics (2020) Vol. 11, Iss. 2, pp. 614-648
Open Access | Times Cited: 305
In vivo gene delivery mediated by non-viral vectors for cancer therapy
Reza Mohammadinejad, Ali Dehshahri, Vijay Sagar Madamsetty, et al.
Journal of Controlled Release (2020) Vol. 325, pp. 249-275
Open Access | Times Cited: 201
Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
Ying Zhang, Qiqi Liu, Xinmeng Zhang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 189
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment
Xiaoyu Xu, Chang Liu, Yonghui Wang, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113891-113891
Open Access | Times Cited: 179
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
Matthew Behr, Jing Zhou, Bing Xu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 8, pp. 2150-2171
Open Access | Times Cited: 153
Hybrid Nanosystems for Biomedical Applications
Joshua Seaberg, Hossein Montazerian, Md. Nazir Hossen, et al.
ACS Nano (2021) Vol. 15, Iss. 2, pp. 2099-2142
Open Access | Times Cited: 145
In vivo somatic cell base editing and prime editing
Gregory A. Newby, David R. Liu
Molecular Therapy (2021) Vol. 29, Iss. 11, pp. 3107-3124
Open Access | Times Cited: 133
Spatiotemporal control of CRISPR/Cas9 gene editing
Chenya Zhuo, Jiabin Zhang, Jung‐Hwan Lee, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 121
Engineering nanoparticle toolkits for mRNA delivery
Bing Sun, Weixi Wu, Eshan A. Narasipura, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 115042-115042
Open Access | Times Cited: 52
Metal‐Organic Frameworks for Gene Therapy and Detection
Ya‐Ping He, Daifeng Li, Li Wu, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 12
Closed Access | Times Cited: 50
CRISPR/Cas9 systems: Delivery technologies and biomedical applications
Yimin Du, Yanfei Liu, Jiaxin Hu, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 6, pp. 100854-100854
Open Access | Times Cited: 46
A critical review on metal-organic frameworks (MOFs) based nanomaterials for biomedical applications: Designing, recent trends, challenges, and prospects
Samreen Sadiq, Shoaib Khan, Iltaf Khan, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25521-e25521
Open Access | Times Cited: 25
Smart Nano-Hybrid Metal-Organic Frameworks: Revolutionizing Advancements, Applications, and Challenges in Biomedical Therapeutics and Diagnostics
Dilip Kumar Chandra, Awanish Kumar, Chinmaya Mahapatra
Hybrid Advances (2025), pp. 100406-100406
Open Access | Times Cited: 2
Metal-organic frameworks for virus detection
Ying Wang, Yaqin Hu, Qunye He, et al.
Biosensors and Bioelectronics (2020) Vol. 169, pp. 112604-112604
Open Access | Times Cited: 86
Gene Therapy in the Anterior Eye Segment
Cynthia Amador, Ruchi Shah, Sean Ghiam, et al.
Current Gene Therapy (2021) Vol. 22, Iss. 2, pp. 104-131
Open Access | Times Cited: 68
In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles
Yuyuan Wang, Pawan K. Shahi, Xiuxiu Wang, et al.
Journal of Controlled Release (2021) Vol. 336, pp. 296-309
Open Access | Times Cited: 63
Recent innovations in synthesis/characterization of advanced nano-porous metal-organic frameworks (MOFs); current/future trends with a focus on the smart anti-corrosion features
M.H. Shahini, H. Eivaz Mohammadloo, Mohammad Ramezanzadeh, et al.
Materials Chemistry and Physics (2021) Vol. 276, pp. 125420-125420
Closed Access | Times Cited: 58
Ocular Nanomedicine
Zhimin Tang, Xianqun Fan, Yu Chen, et al.
Advanced Science (2022) Vol. 9, Iss. 15
Open Access | Times Cited: 45
pH‐Responsive Polymer Nanoparticles for Efficient Delivery of Cas9 Ribonucleoprotein With or Without Donor DNA
Ruosen Xie, Xiuxiu Wang, Yuyuan Wang, et al.
Advanced Materials (2022) Vol. 34, Iss. 23
Open Access | Times Cited: 38
Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy
Jing Wei, Jinyu Mu, Yong Tang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 37
RETRACTED: Surface PEGylation of ZIF-8 metal-organic framework based on magnetic hydroxyapatite as a pH/magnetic targeting responsive system for anticancer drug delivery
Vahid Zeyni, Soheyla Karimi, Hassan Namazi
Microporous and Mesoporous Materials (2023) Vol. 354, pp. 112544-112544
Closed Access | Times Cited: 26
Nanobiomaterial vectors for improving gene editing and gene therapy
Shao Wei Hu, Tao Ding, Honghai Tang, et al.
Materials Today (2023) Vol. 66, pp. 114-136
Closed Access | Times Cited: 24
Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management
Khaled S. Allemailem, Saleh A. Almatroodi, Ahmad Almatroudi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7052-7052
Open Access | Times Cited: 22
A Nanozyme-Boosted MOF-CRISPR Platform for Treatment of Alzheimer’s Disease
Jie Yang, Geng Qin, Zhenqi Liu, et al.
Nano Letters (2024) Vol. 24, Iss. 32, pp. 9906-9915
Closed Access | Times Cited: 9
A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances
Rui Wang, Yuan Gao, Anchang Liu, et al.
Journal of drug targeting (2021) Vol. 29, Iss. 7, pp. 687-702
Closed Access | Times Cited: 54
Page 1 - Next Page

Scroll to top